Connect with us

Health

Bharat Biotech is in charge of the manufacture and supply of Covaxin.

Published

on

In response to rising demand for COVID vaccines, Bharat Biotech said on Friday that producing and supplying Covaxin takes time because various procedures and approvals must be in place before it can be used for vaccination. The Hyderabad-based vaccine company stated that a batch of Covaxin takes about 120 days to manufacture, test, and release, depending on the technology framework and regulatory guidelines to be followed.

The company’s statement comes amid the shortage of COVID jabs in the country and demand from various states to enhance the production of vaccines. “As a result, production batches of Covaxin that began in March of this year will only be available for supply in June,” it said in a statement, adding that the manufacturing, testing, release, and distribution of vaccines is a complex and multi-factorial process involving hundreds of steps that necessitates a diverse pool of human resources.

According to the business, highly organised efforts from foreign supply chains, suppliers, regulators, and state and federal government agencies are needed for vaccines to result in actual vaccination of citizens. Vaccine production scale-up is a gradual process that involves many GMP regulatory SOPs (Standard Operating Procedures of Good Manufacturing Practices). Covaxin takes four months to convert into actual vaccination, according to the report.

According to the company, all vaccines supplied in India are required by law to be submitted for testing and release to the Central Drugs Laboratory, according to the Central Drugs Standard Control Organisation (CDSCO) guidelines. The company said that all batches of vaccines supplied to state and federal governments are based on the allocation process obtained from the federal government, and that vaccine supplies take about two days to enter state and federal government depots from the company’s facilities. The vaccines obtained at these depots must then be distributed by state governments to different districts within their states, which takes an additional amount of days, according to the study. 

Governments administer pandemic vaccines to all segments of the population in an equitable manner. Vaccines are then distributed to recipients over a period of time, depending on demand, until they are accessible at vaccination centres,” it continued.

Health

Tamil Nadu becomes the 1st state to have its own genome sequencing lab.

Published

on

Manasa Maddila, Mumbai Uncensored, 6th January 2021:

The whole-genome sequencing (WGS) laboratory of the State Public Health Laboratory (SPHL) has joined the Indian SARS-CoV-2 Genomics Consortium (INSACOG).

Health Minister Ma. Subramanian said there could have been no other State in India that has set up a genome sequencing lab all alone.

In spite of the State having its own genome sequencing lab that was set up at an expense of 4 crores, and initiated on September 14, it was sending tests to labs in Bengaluru, Hyderabad, and Pune that are important for INSACOG for affirming the sequencing of the Omicron variation.

The Indian SARS-CoV-2 Genomics Consortium (INSACOG) has perceived Tamil Nadu’s State Public Health Laboratory to direct entire genome sequencing, which implies the state will don’t really need to send tests to labs in Pune, Bengaluru, or Hyderabad to affirm variations, like Delta and Omicron.

Ma Subramanian remarked, “The state’s public health lab at the Directorate of Medical and Rural Health Services, which is overseen by CM MK Stalin, has set up equipment worth Rs 4 crore for this purpose”.

A senior authority of the Department of Public Health and Preventive Medicine said that around 150 samples can be tried at the same time at the lab and requires no less than five days to get the outcome.

Continue Reading

Health

Delhi And Mumbai See Spike In Covid Cases; Yellow Alert Issued in national capital

Published

on

Aditya Dwivedi, Mumbai Uncensored, 29th December 2021:

The highest COVID-19 cases recorded in the last 6 months have shocked the nation and the authorities. India’s overall tally of COVID-19 cases saw a tremendous increase by 44% from Tuesday with 9,195 cases.

Delhi tops the list with 238 fresh cases of the highly transmissible Covid-19 variant Omicron and the positivity rate rose to 0.89 on December 29th. As a result, a Yellow Alert has been issued in Delhi for the prevention of the further spread of the virus in the region. 

During the briefing, CM Kejriwal said, “As the COVID-19 positivity rate has been above 0.5 percent for the past few days, we are enforcing Level-I (Yellow alert) of the Graded Response Action Plan. 

He added “In the past few days, the number of cases in the capital city and the country is rising. One needs to not worry but exercise caution. Our government is well prepared. The cases reported are mild. Everyone needs to make sure to wear masks and ensure proper social distancing”

Schools, colleges, theatres, entertainment parks, spas, and gyms have been closed till further orders. Public transports, restaurants (can only operate between 8 am-10 pm) are advised to function with 50% of the total capacity while taking proper measures to avoid the spread of the virus. 

The timing of the night curfew has also been changed from ’11 pm-5 am’ to ’10 pm-5 am’. 

A complete halt on social, political, religious, and entertainment gatherings has been imposed by the government.

Gathering in weddings and funerals has been limited to only 20 people while the banquet halls are not allowed to host weddings or any function and remain shut till further orders. Grade-1 officers in the Delhi Government offices will be required to be present with 100% capacity. Meanwhile, the private firms are advised to call 50% of the staff between 9 am-5 pm.

Mumbai sees a sudden surge in covid 19 cases with 1,333 cases on Tuesday, the highest since last 7 months. Government officials expressed their concerns over the issue and gave an indication of imposing stricter restrictions if the cases continue to rise.

Maharashtra Cabinet Minister Aaditya Thackeray stated, “Last week we were reporting 150 cases per day, now we are reporting around 2000 cases per day. Mumbai may cross 2000 per day cases today”

Continue Reading

Health

China enrolls 1st human fatality due to Monkey B infection

Published

on

Manasa Maddila, Mumbai Uncensored, 27th July 2021:

A Beijing-based vet, who was declared as China’s first human contamination case with Monkey B Virus (BV), has kicked the bucket from the infection. However, his nearby contacts are protected from it, for the present, Global Times announced. 

The 53-year-old male worked for an organisation exploring non-human primates. He started showing side effects of queasiness and heaving, a month after he examined two dead monkeys in the beginning of March. The vet looked for treatments in several hospitals, but eventually died on May 27.  Reports conducted by the Chinese Centre for Disease Control and Prevention, said that there were no deadly or even clinically obvious BV contaminations in China earlier. Experts had gathered the cerebrospinal liquid of the veterinarian in April and distinguished him as positive for BV, yet tests of his nearby contacts came out negative.

The virus first broke out in 1932, is an alphaherpesvirus enzootic in macaques of the genus Macaca. It very well may be sent through direct contact and trade of real discharges; it also has a casualty pace of 70-80 percent.  Studies suggested that BV in monkeys may represent a possible danger to Laboratory workers and veterinarians since they are exposed to monkeys occasionally; it is important to wipe out BV during the advancement of explicit microorganism free rhesus settlements and to fortify observation in research centers that work with macaques in China.

Continue Reading

Trending